ESR1 and neoplasm: IGF2BP3 levels were found to be elevated in breast cancer cases with higher tumor grade, ER negative, PR negative, HER2 negative, higher Ki-67 index, and the triple-negative breast cancer (TNBC) molecular subtype (all P<0.05).